CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 19, 2026 · Acquisition

PMCB Acquisition: a negative outcome, -15.1%

On November 19, 2026, PharmaCyte Biotech, Inc. reached its Acquisition. The result was a negative outcome, and the stock moved -15.1% in the window around the event. It had already run -14.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$5.37
1d before
$4.56
Event day
$3.97
1d after
$3.97
5d after

Pre-catalyst setup

-14.3%
30-day run-up
10770%
30-day volatility
0.4×
volume spike